No abstract available.
Anal Canal* ; Rectal Fistula*

No abstract available.
Stomach Neoplasms*

No abstract available.
Colon* ; Lymphangioma, Cystic*

A subperiosteal ganglion has been very rarely reported, since Ollier reported first one in 1864. A subperiosteal ganglion is produced by mucoid degeneration and cyst formation within the periosteum, which results in cortical erosion. The characteristic plain radiolographic appearance of irregular cortical erosion and scalloping, with reactive periosteal bone spicules, has been considered pathognomonic of subperiosteal ganglion. Magnetic resonance imaging is performed to further characterize the soft tissue component of the mass. As in our patient, the characteristic signal intensities of magnetic resonance imaging are especially useful in identifying the lesion as a ganglion and in defining the lobular nature and the anatomical extent. We report here the case of a 35-year-old female who had a sudperiosteal ganglion of the distal radius.
Adult ; Female ; Ganglion Cysts* ; Humans ; Magnetic Resonance Imaging ; Pectinidae ; Periosteum ; Radius*

PURPOSE:Ghrelin is an endogenous ligand of the growth hormone secretagogue receptor, and stomach is the major site of ghrelin secretion. The purpose of this study is to compare the serum ghrelin concentrations between patients with type 2 diabetes mellitus (DM) and normal adults. We studied also whether serum ghrelin levels in the patients with type 2 DM are correlated with body mass index (BMI), serum insulin, lipid profiles, and creatinine levels. METHODS:Forty patients with type 2 DM and forty normal adults were included in this study. We measured heights and weights of the subjects and calculated their BMIs. Blood samples were obtained to measure the ghrelin concentration and their sera were stored at -20degreeC until used. In all subjects, serum ghrelin levels were measured using the commercially available Ghrelin(human) EIA kit. RESULTS:No differences of mean values were detected between the control group and the type 2 diabetic group for age, body weight, BMI, and the levels of serum total cholesterol, triglyceride, HDL cholesterol, and creatinine. But ghrelin level of the type 2 diabetic group (71.1+/-30.5 ng/L) was significantly lower than the control group (139.7+/-36.9 ng/L). In the control group, the ghrelin level showed positive correlation with HDL cholesterol (Pearson's correlation coefficient=0.37, P<0.05). In the diabetic group, the ghrelin level showed weakly positive correlation with insulin concentration. However, there was no significant relationship between serum ghrelin and various parameters in the diabetic patients group. CONCLUSION: In this study, ghrelin concentration in type 2 diabetic patients was lower than that in the control group. In the control group, serum ghrelin concentrations were positively correlated with HDL cholesterol. In the type 2 diabetic group, there was no significant correlation between insulin and ghrelin concentrations.
Adult ; Body Mass Index ; Body Weight ; Cholesterol ; Cholesterol, HDL ; Creatinine ; Diabetes Mellitus ; Diabetes Mellitus, Type 2* ; Ghrelin* ; Humans ; Insulin ; Receptors, Ghrelin ; Stomach ; Triglycerides ; Weights and Measures

No abstract available.
Infant, Newborn ; Jaundice, Neonatal* ; Radionuclide Imaging* ; Technetium Tc 99m Disofenin*

PURPOSE: Asymptomatic urinary retention in the post-partum period is a relatively common problem. We investigated prospectively the incidence and the various risk factors associated with asymptomatic urinary retention in post-partum. MATERIALS AND METHODS: From Feb. 1999 to Apr. 1999, all pregnant women who visited our hospital for delivery were evaluated. Among them 103 women who had undergone vaginal delivery were evaluated, Exclusion criteria were cesarean section, incidental catheter indwelling during delivery, and symptomatic urinary retention. Residual urine volume was measured using BladderScanTM BVI 2500(Diagnostic Ultrasound co.) within 10 minutes after first voiding in immediate post-partum period. Asymptomatic urinary retention was defined as residual urine volume over 150ml. Pre-partal urinary symptoms and various obstetric parameters were evaluated in asymptomatic urinary retention group and normal group as control. Asymptomatic urinary retention group were followed up daily to monitor their post-void residual urine volume. RESULTS: The incidence of asymptomatic urinary retention after vaginal delivery was 13.6%. Factors associated with asymptomatic urinary retention included second stage of labor, episiotomy, and instrumental delivery. There was no relationship between pre-partal lower urinary tract symptoms and post-partal asymptomatic urinary retention. In patients with asymptomatic urinary retention, catheterization was done for removing residual urine and thus preventing progression of further distension. Post-void residual volume was normalized within 3 days in all patients. CONCLUSIONS: Asymptomatic post-partum urinary retention is a self-limiting phenomenon associated with various traumatic events during hard labor such as prolonged labor, episiotomy, instrumental delivery. Close observation of voiding patterns in patients with risk factors is needed to prevent myogenic failure associated with unrecognized asymptomatic post-partum urinary retention.
Catheterization ; Catheters ; Cesarean Section ; Episiotomy ; Female ; Humans ; Incidence ; Lower Urinary Tract Symptoms ; Pregnancy ; Pregnant Women ; Prospective Studies* ; Residual Volume ; Risk Factors ; Ultrasonography ; Urinary Retention*

No abstract available.
Arthroplasty* ; Hip*

INTRODUCTION: Percutaneous transluminal angioplasty(PTA) has been widely accepted for the treatment of arterial stenosis. However, acute thrombosis, localized dissection or recoiling may occur as complication, resulting in acute occlusion. Restenosis is also a problem in long term follow up. Recent advance of metallic stent is considered as a good relief for the problems of PTA. PURPOSE: We analyzed 11 patients with metallic stent in the treatment of the iliac artery stenosis. METHOD: Subjects were male patients aged from 53 to 79 years old. All were suffered from claudication of lower extremities, pain and discolorization and diagnosed as atherosclerosis. Pelvic arteriography was performed to localize the stenotic lesion. Through the ipsilateral arterial puncture, metallic stent was inserted after PTA. The metallic stents were Wall stent in 7, Hanaro stent in 2, Palmaz stent 2 and Memotherm stent in 2 lesions. RESULT: The indications for metallic stent were long segment patients, in all cases, the stent was successfully inserted. The pressure gradient measured improved significantly after procedure. For the 3 to 24 months follow up, symptoms has not relapsed clinically. CONCLUSION: On the basis of our priliminary experience, Metallic stent is safe and effective for the treatment of iliac arterial stenosis in conjunction with PTA and surgery.
Aged ; Angiography ; Atherosclerosis ; Constriction, Pathologic ; Follow-Up Studies ; Humans ; Iliac Artery ; Lower Extremity ; Male ; Punctures ; Stents ; Thrombosis

PURPOSE: This study was done to evaluate the efficacy and safety of percutaneous sclerotherapy or endovascular treatment of hemangioma and venous malformation. METHODS: 9 interventional procedures were performed in 7 patients whose age ranged from 16 years to 52 years. Five of these patients had arteriovenous malformation, the remaining had hemangioma and venous malformation. N-buty1-2-cyanoacrylate was injected percutaneously in 4 procedures and intraarterially in one procedure. Ethanol with lipiodol(10%) was injected percutaneously in 2 procedures. 1valon particle was embolized intraarterial in 1 procedure. RESULTS: N-buty1-2-cyanoacrylate injection, Contour arterial embolozation, Etanole with lipiodo1, sclerotherapy followed by physician and was judged beneficial in 7 of 7 patients. One pateint had minor complication(skin ulcer) but no long term sequelae. CONCLUSIONS: Percutaneous sclerotherapy and endovascular treatment, either or before surgery is a safe and effective method of managing hemangioma and arteriovenous malformations.
Arteriovenous Malformations ; Ethanol ; Hemangioma ; Humans ; Sclerotherapy